Dr. Mima Geere, MD, MS, IFMCP, Director, Precision Pathology, Systems Biology and Research at The American Board of Precision Medicine is a trailblazer in systems-based longevity and integrative diagnostics. She brings over a decade of industry experience working at the convergence of technology and precision medicine, with a strong foundation in startup environments and translational research.
With a foundation in clinical pathology from UCSF and advanced training in clinical informatics and environmental toxicology, she combines rigorous scientific inquiry with functional medicine principles.
As Director of Precision Pathology, Systems Biology, and Research at The American Board of Precision Medicine and Founder of Mimansa, Dr. Geere pioneers multi-omics frameworks that integrate genomics, metabolomics, and AI-driven modeling into personalized, ethical healthcare pathways. Her approach combines mind-body medicine and systems thinking with cutting-edge diagnostics, emphasizing holistic longevity strategies and a commitment to using science as the benchmark to advance knowledge and clinical care. Her vision centers on elevating truth as the core metric in medicine through real-world data, digital twin simulation, and blockchain-enabled research collaboration.
Founder, Mimansa; Clinical Pathologist (UCSF); Functional Medicine Expert; Postdoctoral Training in Clinical Informatics and Environmental Toxicology

Director of Precision Pathology, Systems Biology and Research

Dr. Ben Schanker MD, MBA, MPH is a Preventive Medicine specialist at Stanford University, where he is Clinical Assistant Professor in the Division of Primary Care and Population Health. He is a graduate of Harvard Medical School, Johns Hopkins Bloomberg School of Public Health, and Oxford Said Business School. After preliminary Internal Medicine at Yale and residency/fellowship training at the University of California, San Francisco (UCSF), he practiced community health in California’s Central Valley, with a focus on treating neuromusculoskeletal and orthopedic spine/sports injuries. He brings over a decade of leadership experience in systems quality improvement to the board, having served as an Expert Consultant for the World Health Organization and on leadership teams of the American Medical Association Foundation and Massachusetts Medical Society. He is the father of bulldogs and enjoys organic farming and international travel in his free time.

Director of Precision Preventive Medicine

Dr. Joseph Purita is a board-certified orthopedic surgeon with over 20 years of expertise in cellular and anti-aging therapies within the field of Regenerative Medicine. He completed his medical education and training at Georgetown University and has since become a recognized leader in advancing innovative treatment approaches.
A sought-after speaker, Dr. Purita has lectured extensively worldwide on various topics related to regenerative medicine. He was the inaugural president of the American Academy and Board of Regenerative Medicine and currently serves as the Medical Director of Pur-Form and its nationwide network.
His contributions to the field include numerous scientific publications and book chapters, reflecting his dedication to research and education. Recently, he was appointed Professor of Regenerative Medicine at the University of Max Planck in Indaiatuba, Brazil, further solidifying his influence in the global medical community.
Dr. Purita remains committed to pioneering advancements in regenerative medicine, helping patients achieve optimal health and longevity through cutting-edge cellular therapies.

Director of Regenerative Precision Medicine

Dr. Sanjay Bhojraj is a visionary leader in cardiovascular health, merging interventional cardiology with precision and functional medicine. As one of the few cardiologists certified in Functional Medicine through the Cleveland Clinic-affiliated Institute of Functional Medicine, he reimagines heart health by addressing root causes of disease.His practice employs advanced cardiac imaging, comprehensive lipid analysis, and "omics" technologies—genomics, proteomics, and metabolomics—to assess individual cardiovascular risk beyond population-based models. This approach enables precise diagnostics and bespoke treatment plans that integrate longevity, functional, and conventional medicine for lasting health transformation.
Dr. Bhojraj is the creator of Well12, a 10-week wellness program promoting lasting lifestyle changes through nutrition, sleep, movement, and mindset. Rooted in functional medicine principles, it emphasizes the gut-brain connection and holistic well-being. Participants experience significant improvements in energy, clarity, and overall health.
A dynamic educator and speaker, he offers breathwork courses, wellness challenges, and live wellness sessions. He is also establishing educational programs to teach doctors how to apply functional and precision medicine in their practice and to take on leadership roles in the MedTech industry. Committed to building communities for both patients and doctors, Dr. Bhojraj fosters environments where learning, support, and transformation can thrive. His personal journey toward optimal health informs his mission to inspire others to "do what they're supposed to do" for lasting well-being.
As a devoted husband and father of triplet daughters, Dr. Bhojraj values presence and vitality in all aspects of life. His work reflects a modern, integrated approach to cardiology that empowers patients to transform their health from the inside out.

Director of Precision Cardiology

Andy R. Eugene, MD, PhD, FCP, DABCP is board-certified by the American Board of Clinical Pharmacology, a Fellow of the American College of Clinical Pharmacology, and is an expert on pharmacogenomics and adverse drug events. Dr. Eugene completed post-graduate training at the Mayo Clinic in Rochester, Minnesota in Clinical Pharmacology and later worked on the institutional-wide implementation of Pharmacogenomics for the Mayo Clinic Center for Individualized Medicine. Clinically, Dr. Eugene is credentialed in Psychiatry at Larned State Hospital, is an International Associate of the Royal College of Psychiatrists (UK), an Associate of the Royal College of Physicians (UK), and a Member of the American Medical Association.
Dr. Eugene is experienced in EEG Brain Mapping in Psychopharmacology and has experience in Phase I Clinical Trials, Drug-Drug Interaction Studies, Clinical Trials in Clinical Pharmacology, Population Pharmacokinetics and Pharmacodynamics (PK/PD) Modeling and Simulation, Non-Compartmental Analysis and Toxicokinetic Analysis, Data Science with Genomics Single-Nucleotide Polymorphism Datasets, and has an interest in Pharmacovigilance analysis of Adverse Drug Events data from the US FDA Adverse Events Reporting System.

Director of Clinical Pharmacogenomics

Physician, CEO of Progenabiome and Ventura Clinical Trials, Co-founder of Topelia Therapeutics; Expert on the Gut Flora (Microbiome) and cutting-edge medical research;
Writer, Editor, World-Renowned Speaker, Published Author of “Let’s Talk Sh!t” , Regenesis
MD: University of Miami, Residency: Jackson Memorial Hospital, Fellowship: University of Florida
As the first woman accepted into the University of Florida as a Clinical Gastroenterology Fellow, Dr. Sabine Hazan is a pioneer in the medical field. She has published articles in numerous prestigious medical journals, and is the Series Editor on the microbiome for Practical Gastroenterology, a peer review journal that reaches 18,000 gastroenterologists. She is also a speaker for the World Congress of Digestive Disease, MAGI, Microbiome Congress, ILADS, TACA, International Drug Discovery Science and Technology Conference and NIST (National Institute of Standards and Technology). As a specialist in gastroenterology, internal medicine, and hepatology, Dr. Hazan has used her medical expertise in many regards over the last two decades.
Dr. Hazan is the CEO of Ventura Clinical Trials, where she has 20+ years experience leading clinical trials for cutting-edge research on various medical issues and has done over 300 clinical trials for pharmaceutical companies. Since March 2020, she has been at the forefront of COVID-19 research, leading ongoing FDA-approved clinical trials for treatment and prophylaxis ON Hydroxychloroquine, Zpack, VIT C D , Zinc And IVM.
She is also the founder & CEO of Progenabiome, a genetic sequencing research laboratory, she leads 35+ studies investigating the role of the gut flora in various diseases.
Through their study exploring the role of the gut flora in COVID-19, Progenabiome became the first lab worldwide to detect SARS-CoV-2 from Patient Fecal Samples by Whole Genome Sequencing and the lab that showed a susceptibility marker for COVID in the microbiome.
Dr Hazan is mastering Familial fecal transplant showing hope for kids with Autism. She created The Malibu Microbiome meeting where physicians who perform fecal transplant can discuss their findings freely.

Director of Precision Gastroenterology

Born in Sudbury, Ontario, Dr. Haaland has dedicated his career to advancing patient care in allergy, immunology, and rheumatology. He earned his Bachelor of Science in Biomedical Sciences and Master of Science in Nutritional Sciences from the University of Guelph before pursuing his Doctor of Medicine (MD) at Dalhousie University.
Dr. Haaland completed his Internal Medicine residency at McMaster University, followed by a combined fellowship in Allergy & Immunology and Rheumatology, and later, the prestigious Geoff Carr Lupus Fellowship. His extensive training has positioned him as a leader in the diagnosis and treatment of complex autoimmune and inflammatory conditions.
Currently, Dr. Haaland serves as an Associate Clinical Professor at McMaster University and an Assistant Professor at the Northern Ontario School of Medicine in Sudbury, where he is actively involved in medical education and mentorship.
He now resides in Shanty Bay with his wife and three sons and recently relocated his practice from Barrie to Orillia, where he continues to provide expert care to his patients.

Director of Immunology

Dr. Raffaele has been practicing longevity medicine for 25 years and has published clinical studies in telomere biology, epigenetics, hormone therapy, and glycobiology. He is the CEO and CMO of the software company he co-founded, PhysioAge Health Analytics, which enables longevity practices around the world to practice precision, n-of-1 longevity medicine more effectively than traditional EHRs. He routinely writes about longevity medicine on Raffaelemedical.com, PhysioAge.com, and @RaffaeleMD.

Director of Longevity Medicine

Olivia Levine, MD, PhD is a neuropsychiatrist with expertise in addiction and mood disorders. Her PhD research focused on neural circuits, particularly a thalamic-amygdalar circuit involved in alcohol use and anxiety behaviors, uncovering key sex differences. During her medical training, she studied iron metabolism protein expression in schizophrenia patients. Dr. Levine is dedicated to understanding the molecular, circuit, and behavioral complexities of psychiatric disorders to inform targeted treatments.

Neuropsychiatry Adjunct Faculty

Oluyemisi Famuyiwa, MD is a board-certified Reproductive Endocrinologist and the Founder and Medical Director of Montgomery Fertility Center in Rockville, Maryland. She completed her fellowship in Reproductive Endocrinology and Infertility at the National Institutes of Health and serves as an Associate Clinical Professor at George Washington University School of Medicine. Dr. Famuyiwa is the author of the forthcoming book The Quest for Fertility and the host of the Fertile Talks podcast, where she bridges clinical insights with empowering fertility education. A frequent media guest and thought leader, she is currently developing The Fertility Blueprint Lab, a concierge program that applies precision medicine, systems biology, and exposomic analysis to reproductive health.

Director of Precision Reproductive Endocrinology

Dr. Saeed Shaikh, M.D.,F.R.C.P.C., is the co-founder of Precision Longevity Inc. and Director of the Niagara Peninsula Arthritis Centre. A native of Toronto, Dr. Shaikh received his Bachelor of Arts from the University of Toronto and Doctor of Medicine from the Royal College of Surgeons in Ireland. He completed his Residency in Internal Medicine at the Medical Center of Delaware and Fellowship in Rheumatology at Georgetown University in Washington, DC. He has completed board certifications in both Internal Medicine and Rheumatology in the United States and Canada. He has served on the Board of Directors for the Canadian Rheumatology Research Consortium and is currently an Assistant Clinical Professor at McMaster University. Dr. Shaikh also presently serves on the Scientific Advisory Council for Osteoporosis Canada and is an active member of the Healthy Longevity Medicine Society.

Director of Precision Rheumatology

Medical Leadership